Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Crystal Oechsle"'
Autor:
Loral E Showalter, Crystal Oechsle, Nirmala Ghimirey, Chase Steele, Brian J Czerniecki, Gary K Koski
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210209 (2019)
The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferation for multiple types of cancer. Members have therefore become thefocus of many drug and immune-based therapy innovations. The targeted anti-cancer a
Externí odkaz:
https://doaj.org/article/c03405373729410b9178d5339be5e21b
Autor:
Lea Lowenfeld, Salman Zaheer, Crystal Oechsle, Megan Fracol, Jashodeep Datta, Shuwen Xu, Elizabeth Fitzpatrick, Robert E. Roses, Carla S. Fisher, Elizabeth S. McDonald, Paul J. Zhang, Angela DeMichele, Rosemarie Mick, Gary K. Koski, Brian J. Czerniecki
Publikováno v:
OncoImmunology, Vol 6, Iss 9 (2017)
HER2-directed therapies are less effective in patients with ERpos compared to ERneg breast cancer, possibly reflecting bidirectional activation between HER2 and estrogen signaling pathways. We investigated dual blockade using anti-HER2 vaccination an
Externí odkaz:
https://doaj.org/article/40a1bfb17d064e669d6b75faf357fb2e
The human microbiome has begun to emerge as a potential forensic tool, with varied applications ranging from unique identification to investigative leads that link individuals and/or locations. The relative abundance of the combined DNA of the microb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::397254427a9bd1bead42682ab4ea37f1
https://doi.org/10.22541/au.163355941.14332340/v1
https://doi.org/10.22541/au.163355941.14332340/v1
Publikováno v:
Vaccines
Volume 8
Issue 1
Vaccines, Vol 8, Iss 1, p 72 (2020)
Volume 8
Issue 1
Vaccines, Vol 8, Iss 1, p 72 (2020)
A dendritic cell-based, Type 1 Helper T cell (Th1)-polarizing anti-Human Epidermal Growth Factor Receptor-2 (HER-2) vaccine supplied in the neoadjuvant setting eliminates disease in up to 30% of recipients with HER-2-positive (HER-2pos) ductal carcin
Autor:
Crystal Oechsle, Brian J. Czerniecki, Gary K. Koski, Chase Steele, Loral E Showalter, Nirmala Ghimirey
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 1, p e0210209 (2019)
PLoS ONE, Vol 14, Iss 1, p e0210209 (2019)
The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferation for multiple types of cancer. Members have therefore become thefocus of many drug and immune-based therapy innovations. The targeted anti-cancer a
Autor:
Lea, Lowenfeld, Salman, Zaheer, Crystal, Oechsle, Megan, Fracol, Jashodeep, Datta, Shuwen, Xu, Elizabeth, Fitzpatrick, Robert E, Roses, Carla S, Fisher, Elizabeth S, McDonald, Paul J, Zhang, Angela, DeMichele, Rosemarie, Mick, Gary K, Koski, Brian J, Czerniecki
Publikováno v:
Oncoimmunology. 6(9)
HER2-directed therapies are less effective in patients with ERpos compared to ERneg breast cancer, possibly reflecting bidirectional activation between HER2 and estrogen signaling pathways. We investigated dual blockade using anti-HER2 vaccination an
Autor:
Gary K. Koski, Carla S. Fisher, Crystal Oechsle, Paul J. Zhang, Elizabeth Fitzpatrick, Angela DeMichele, Elizabeth S. McDonald, Brian J. Czerniecki, Shuwen Xu, Rosemarie Mick, Jashodeep Datta, Robert E. Roses, Salman Zaheer, Lea Lowenfeld, Megan Fracol
Publikováno v:
OncoImmunology, Vol 6, Iss 9 (2017)
HER2-directed therapies are less effective in patients with ERpos compared to ERneg breast cancer, possibly reflecting bidirectional activation between HER2 and estrogen signaling pathways. We investigated dual blockade using anti-HER2 vaccination an